# Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae

> **NIH NIH N01** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2022 · $3,074,366

## Abstract

The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies.

## Key facts

- **NIH application ID:** 10691836
- **Project number:** 272201300012I-P00002-759301900131-1
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** JEANNE M MARRAZZO
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $3,074,366
- **Award type:** —
- **Project period:** 2019-09-06 → 2023-09-05

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10691836

## Citation

> US National Institutes of Health, RePORTER application 10691836, Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae (272201300012I-P00002-759301900131-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10691836. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*